6.
Hata M, Omura M, Koike I, Tomita N, Iijima Y, Tayama Y
. Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma. Int J Radiat Oncol Biol Phys. 2010; 81(5):1387-93.
DOI: 10.1016/j.ijrobp.2010.07.1992.
View
7.
Kim S, Lee W, Oh S, Yang D, Kim H, Park S
. Relapse in patients with limited-stage ocular adnexal lymphoma treated by chemoimmunotherapy: Extended follow-up of a phase 2 study. Cancer Med. 2022; 11(14):2817-2823.
PMC: 9302339.
DOI: 10.1002/cam4.4639.
View
8.
Borger F, Rosenberg I, Vijayakumar S, Virudachalam R, Schneider D, Langmuir V
. An anterior appositional electron field technique with a hanging lens block in orbital radiotherapy: a dosimetric study. Int J Radiat Oncol Biol Phys. 1991; 21(3):795-804.
DOI: 10.1016/0360-3016(91)90700-e.
View
9.
Park H, Lee S, Sung S, Choi B
. Treatment outcome and risk analysis for cataract after radiotherapy of localized ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma. Radiat Oncol J. 2017; 35(3):249-256.
PMC: 5647758.
DOI: 10.3857/roj.2017.00374.
View
10.
Desai A, Joag M, Lekakis L, Chapman J, Vega F, Tibshirani R
. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study. Blood. 2016; 129(3):324-332.
DOI: 10.1182/blood-2016-05-714584.
View
11.
Jereb B, Lee H, Jakobiec F, Kutcher J
. Radiation therapy of conjunctival and orbital lymphoid tumors. Int J Radiat Oncol Biol Phys. 1984; 10(7):1013-9.
DOI: 10.1016/0360-3016(84)90172-x.
View
12.
Nam H, Ahn Y, Kim Y, Ko Y, Kim W
. Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma. Radiother Oncol. 2008; 90(2):236-41.
DOI: 10.1016/j.radonc.2008.09.011.
View
13.
Olsen T, Holm F, Mikkelsen L, Rasmussen P, Coupland S, Esmaeli B
. Orbital Lymphoma-An International Multicenter Retrospective Study. Am J Ophthalmol. 2018; 199:44-57.
DOI: 10.1016/j.ajo.2018.11.002.
View
14.
Suh C, Shim S, Lee S, Yang W, Lee S, Hahn J
. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior. Int J Radiat Oncol Biol Phys. 2006; 65(1):228-33.
DOI: 10.1016/j.ijrobp.2005.11.035.
View
15.
Dunbar S, Linggood R, Doppke K, Duby A, Wang C
. Conjunctival lymphoma: results and treatment with a single anterior electron field. A lens sparing approach. Int J Radiat Oncol Biol Phys. 1990; 19(2):249-57.
DOI: 10.1016/0360-3016(90)90531-n.
View
16.
Yahalom J, Illidge T, Specht L, Hoppe R, Li Y, Tsang R
. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015; 92(1):11-31.
DOI: 10.1016/j.ijrobp.2015.01.009.
View
17.
Platt S, Al Zahrani Y, Singh N, Hill B, Cherian S, Singh A
. Extranodal Marginal Zone Lymphoma of Ocular Adnexa: Outcomes following Radiation Therapy. Ocul Oncol Pathol. 2017; 3(3):181-187.
PMC: 5675111.
DOI: 10.1159/000453615.
View
18.
Imber B, Chau K, Lee J, Lee J, Casey D, Yang J
. Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?. Blood Adv. 2021; 5(20):4185-4197.
PMC: 8945632.
DOI: 10.1182/bloodadvances.2021004939.
View
19.
Mizuhara K, Kobayashi T, Nakao M, Takahashi R, Kaneko H, Shimura K
. Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective study. Cancer Med. 2022; 12(3):3134-3144.
PMC: 9939164.
DOI: 10.1002/cam4.5237.
View
20.
Lee J, Yoon J, Kim J, Koom W, Cho J, Suh C
. Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization. Jpn J Clin Oncol. 2019; 49(7):664-670.
DOI: 10.1093/jjco/hyz044.
View